Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Harald Schramm"'
Publikováno v:
Journal of Obesity, Vol 2011 (2011)
Background. Gastric banding (GB) is a common bariatric procedure that is performed worldwide. Weight loss can be substantial after this procedure, but it is not sufficient in a significant portion of patients. Long-term rates for associated complicat
Externí odkaz:
https://doaj.org/article/1be1dea7bbdf409a95c3aea783b7e98d
Publikováno v:
Visceral Medicine. 23:13-18
Adjustable gastric banding is a popular bariatric operation worldwide. The rate of long-term complications such as pouch dilatation, slippage and band migration and the long-termeffect of weight loss are reported inameta-analysis and few studies for
Publikováno v:
Zentralblatt für Chirurgie. 130:410-418
BACKGROUND: Adjustable gastric banding is a popular bariatric operation in Europe. The rate of long-term complications like pouch dilatation, slippage and band migration and the long-term effect of weight loss are reported in meta-analysis and few st
Publikováno v:
Pancreas. 24:210-214
Introduction A differential therapy of chronic pancreatitis and carcinoma calls for evaluation of the validity of findings. Presurgical suspicion of a carcinoma often requires intrasurgical diagnostics such as excisional biopsies, punch biopsies, and
Autor:
Christine Stroh, Harald Schramm
Publikováno v:
Zentralblatt für Chirurgie. 125:682-687
BACKGROUND Since 1983 gastric banding has become a proven operative method, which reduces effectively excess weight in morbid obesity. Gastric banding has been popularized as a minimally invasive, completely reversible surgical treatment for morbid o
Autor:
Johann Hauss, Karl-Walter Jauch, Albrecht Encke, Hans-Helge Müller, Hans-Günther Rau, Matthias W. Lorenz, Wolf O. Bechstein, Karsten Ridwelski, Heinz-Jochen Gassel, Harald Schramm, Rudolf Stieger
Publikováno v:
Annals of Surgery. 228:756-762
Objective To determine the impact of adjuvant hepatic arterial infusion (HAI) on survival relative to resection alone in patients with radical resection of colorectal liver metastases. Background Data Nearly 40% to 50% of all patients with colorectal
Publikováno v:
Coloproctology. 20:191-197
The transanal endosonography is today standard in the pre-operative staging of carcinoma of the rectum. The reliable results allow for differential therapy in dependence of tumor penetration depth. With the introduction of the 3-dimensional ultrasoun
Autor:
Marko, Kornmann, Wolfgang, Schwabe, Silvia, Sander, Martina, Kron, Jörn, Sträter, Sucan, Polat, Erika, Kettner, Hans F, Weiser, Wolfram, Baumann, Harald, Schramm, Peter, Häusler, Kati, Ott, Detlev, Behnke, Ludger, Staib, Hans G, Beger, Karl H, Link
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(11)
Despite adjuvant 5-fluorouracil (5-FU) therapy, approximately 30% of patients with International Union against Cancer stage II and III colorectal cancer develop recurrence. In this study, we determined the prognostic value of thymidylate synthase (TS
Autor:
Harald Schramm, Bernhard Leibl, Karsten Ridwelski, Peter Scholz, Karl H. Link, Kati Ott, Ernst D Kreuser, Jürgen H Vogt, Jörn Sträter, D. Behnke, Christoph Schlichting, Sucan Polat, Klaus-Ullrich Zerbian, Hans G. Beger, E. Kettner, Inga Galuba, Marko Kornmann, Peter Häusler, Ute Hecker, Wolfgang Schwabe, Wolfram Baumann, Frank Schütze
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 6(3)
Patients with International Union Against Cancer (UICC) stage IIb and III colon cancer and stage II and III rectal cancer may receive adjuvant chemotherapy with 5-fluorouracil (5-FU). High levels of thymidylate synthase (TS) and dihydropyrimidine deh
Autor:
Peter Neuhaus, Klaus Gutberlet, Stefan Post, Harald Schramm, Ingo G.H. Schmidt-Wolf, Karsten Ridwelski, Wolf O. Bechstein, Harald Schmalenberg, Carl Zuelke, Hanno Riess, Klaus Gellert, Karin Weigang-Koehler, E. Kettner, Jan M. Langrehr, Lars Roll, J. Fahlke, Christof Burkart, Bernd Doerken, Marco Niedergethmann, Helmut Oettle
Publikováno v:
JAMA. 297:267
ContextThe role of adjuvant therapy in resectable pancreatic cancer is still uncertain, and no recommended standard exists.ObjectiveTo test the hypothesis that adjuvant chemotherapy with gemcitabine administered after complete resection of pancreatic